论文部分内容阅读
目的:观察应用普拉克索治疗帕金森患者的临床疗效。方法:随机选取2012年3月-2014年3月我院收治的96例帕金森患者作为研究对象,按照数字法分为对照组(n=48)和观察组(n=48),对照组给予溴隐亭治疗,观察组给予普拉克索治疗,比较两组患者的治疗效果。结果:观察组患者的总有效率97.9%显著优于对照组81.3%,差异具有统计学意义(P<0.05)。结论:应用普拉克索治疗帕金森效果显著,安全可靠,无明显不良反应,值得临床使用和积极推广。
Objective: To observe the clinical efficacy of pramipexole in the treatment of Parkinson’s disease. Methods: A total of 96 Parkinson’s patients admitted to our hospital from March 2012 to March 2014 were randomly selected as the control group (n = 48) and the observation group (n = 48) according to the digital method. The control group Bromocriptine treatment, the observation group given pramipexole treatment, the treatment effect of two groups were compared. Results: The total effective rate in observation group was significantly higher than that in control group (97.9% vs 81.3%, P <0.05). Conclusion: The treatment of Parkinson with pramipexole is effective, safe and reliable, with no obvious adverse reactions. It is worth clinical application and promotion.